Small Cell Lung Cancer (SCLC) Medical Education Grants
- Second-line treatment options and therapy sequencing in SCLC management
- Current considerations in first-line maintenance and second-line SCLC therapies including:
- Efficacy
- Safety
- Mechanism of action
- Evidence-based best practices
- Best practices for patient management in first and later lines of SCLC treatment
- Evidence based managed care considerations for SCLC management (1L and subsequent therapies)
Jazz Pharmaceuticals (JAZZ) is committed to advancing scientific knowledge and clinical expertise within the medical and scientific communities with the ultimate goal of improving patient care.
This site allows you to submit Independent Medical Education (IME) requests for US and Ex-US activities or initiatives that serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of healthcare professionals (e.g., continuing medical education, continuing health education, continuing education).
IME is supported education (accredited or non-accredited) in which JAZZ exercises no control, influence, or direction over any aspect of the program, including but not limited to educational design, faculty, authors, speakers, etc. All grants must comply with local regulations.
We are currently accepting requests for:
- Meetings, Conferences, or Symposia
- Medical Center Grand Rounds lectures
- Fellowships
- Enduring IME activities, which may include strategies, tools, and other educational resources to use with patients
- Patient education in conjunction with Health Care Provider (HCP) education
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.